and the Haemophilia Centre, Royal Free Hospital, London2 SYNOPSIS The factor VIII clotting activity (VIII) and factor VIII related antigen (VIIIRAg) were determined repeatedly in 24 pairs of age-matched normal women, one of each pair being on oral contraceptives. No significant differences in either parameter or in the VIIIC/VIIIRAg ratio were found between the two groups, although the mean factor VIII clotting activity and VIIIc/VIIIRAg ratios for women on oral contraceptives were very slightly higher than for those not on oral contraceptives.
The demonstration by Zimmerman et al (1971) that the ratio VIIIc/VIIIRAg is decreased in carriers of haemophilia has led to a more reliable method of identifying the carrier state than is possible when only factor VIII clotting activity is measured. Since many suspected carriers of haemophilia take oral contraceptives, it is important to determine whether the use of these drugs results in a change of the VI11/VIIIRAg ratio. Egeberg and Owren (1963) found that they led to an increase in the level of factor VIII clotting activity in normal women while Schiffman and Rapaport (1966) found an increase in factor VIII clotting activity levels in suspected carriers of haemophilia who were taking oral contraceptives. Their effect on factor VIII related antigen has not been previously reported. We Since the distribution for both factor VIII clotting activity and factor VIII related antigen was approximately log normal in type, log transformations were used for the analysis of these results. The values for VIIc/VIIIRAg ratios followed a normal distribution and were analysed without transformation. Student's t test was used to compare the results of the two groups of women for each factor VIII clotting assay method and technician separately, each factor VIII related antigen determination, and the Vlllc/VIIIBAg ratios derived from each relevant pair of determinations.
Results
The results for both groups of patients are summarized in the Table. There was no significant difference between the two groups of women in either factor VIII clotting activity, factor VIII related antigen, or VIlIc/VIIIRAg ratio, although for each factor VIII clotting assay method the mean for the group of women taking oral contraceptives was slightly higher than the corresponding mean for the control group.
The results were also analysed separately for the five different age groups but showed no significant difference.
Individual analysis of the different factor VIII clotting assays showed a slightly wider variation in the one-stage assay although in the overall means there was no significant difference between the oneand two-stage assays.
A VIIc/VIIIRAg ratio of less than 0 7 was obtained in eight women (four on oral contraceptives and four controls) when this was calculated on the basis of a single factor VIII clotting assay (by any of the three methods) and one immunoassay. 
